# Diaplex and Glycemic Control

> **NCT07711587** · NA · NOT_YET_RECRUITING · sponsor: **Standard Process Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Insulin Sensitivity
- Healthy Adult

## Interventions

- **DIETARY_SUPPLEMENT:** Diaplex
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07711587
- **Lead sponsor:** Standard Process Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2027-10-30
- **Final completion:** 2027-12-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07711587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07711587, "Diaplex and Glycemic Control". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07711587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*